Pre-treatment quality determines final ZLD reliability in pharma
Pharmaceutical effluent often combines high COD, variable solvents, and intermittent toxic shocks. Sending this directly to evaporation or membranes increases fouling and upset frequency.
Characterize streams by biodegradability, toxicity, and solvent profile before selecting treatment trains. One-size-fits-all process schemes fail quickly in multiproduct facilities.
Use segregation at source for solvent-heavy, high-salt, and biologically treatable streams. Proper segregation lowers chemical use and improves process stability.
Equalization with controlled dosing and oxidation can smooth sudden COD spikes. The objective is not only compliance but protection of downstream assets.
Membrane and evaporation sections should receive conditioned feed with predictable pH and suspended solids. Stable feed quality extends cleaning intervals and keeps throughput steady.
Track success using specific KPIs: feed COD variability, fouling rate, chemical per KL, and unplanned downtime. These metrics reveal whether pre-treatment is genuinely effective.